Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Testosterone cream for low sexual desire with personal distress in premenopausal/perimenopausal women
ACTRN12625001376437Phase 3Recruiting
- Sponsor
- Monash University
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in hypoactive sexual desire disorder (HSDD) and female sexual dysfunction (FSD) comparing Testosterone cream with Placebo cream (2 arms). Primary endpoint: Change in sexual desire. Started Jan 2026; status: recruiting.
02
Drugs
testosterone
03
Conditions
hypoactive sexual desire disorder (HSDD)female sexual dysfunction (FSD)
Beyond the preview
Go deeper on ACTRN12625001376437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12625001376437.